CRISIL NSE filing

CRISIL Board Meeting on Apr 16-17 to Approve Q1 FY26 Results & Interim Dividend

The RealCase readMedium impact Neutral

CRISIL's Board will meet on April 16-17, 2026, to approve Q1 FY26 results and consider an interim dividend for FY26. The trading window is closed from March 16, 2026, to April 21, 2026.

Why it matters

The announcement is of medium impact as it informs about the upcoming board meeting to approve financial results and dividend, which are material information for investors. The trading window closure is a standard regulatory procedure.

The market read

The announcement is a routine disclosure regarding a board meeting to approve financial results and consider dividend payment, along with a trading window closure. It does not contain new financial performance data or significant strategic changes that would warrant a positive or negative sentiment.

CRISIL Limited has announced that a meeting of its Board of Directors will be held on Thursday, April 16, 2026, and Friday, April 17, 2026. The board will convene to consider and approve the unaudited consolidated and standalone financial results for the first quarter ended March 31, 2026.

Additionally, the board will consider the payment of the first interim dividend for the financial year ending December 31, 2026. The unaudited financial results for the first quarter ended March 31, 2026, along with the proposal for dividend, are scheduled for presentation to the Board on April 17, 2026, for their final approval.

Furthermore, the company has informed that the 'No Trading Window' for its employees and subsidiaries has commenced from March 16, 2026, and will remain operative until April 21, 2026, inclusive, in accordance with its Insider Trading Code. This period is 15 days prior to the close of the previous quarter.

Filing to action

What to do with a filing like this

CRISIL Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by CRISIL Limited. Read the original for the full detail.

View original filing